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Background: . The occurrence of trans-placental transmission of severe acute respiratory syndrome corona
virus 2 (SARS-CoV-2) infection remains highly debated. Placental positivity for SARS-CoV-2 has been
reported in selected cases, but infection or virus-associated disease of fetal tissues or newborns remains to
be demonstrated.
Methods: We screened for SARS-CoV-2 spike (S) protein expression placentas from 101 women who
delivered between February 7 and May 15, 2020, including 15 tested positive for SARS-CoV-2 RNA, 34 tested
negative, and 52 not evaluated as they did not meet testing criteria (32), or delivered before COVID-19 pan-
demic declaration (20). Immunostain for SARS-CoV-2 nucleocapsid (N) was performed in the placentas of all
COVID-19 positive women. One placenta resulted positive for the SARS-CoV-2 S and N proteins, which was
further studied by RNA-in situ hybridization and RT-PCR for S transcripts, and by electron microscopy.
A comprehensive immunohistochemical and immunofluorescence analysis of the placental inflammatory
infiltrate completed the investigations.
Findings: SARS-CoV-2 S and N proteins were strongly expressed in the placenta of a COVID-19 pregnant
woman whose newborn tested positive for viral RNA and developed COVID-19 pneumonia soon after birth.
SARS-CoV-2 antigens, RNA and/or particles morphologically consistent with coronavirus were identified in
villous syncytiotrophoblast, endothelial cells, fibroblasts, in maternal macrophages, and in Hofbauer cells
and fetal intravascular mononuclear cells. The placenta intervillous inflammatory infiltrate consisted of
neutrophils and monocyte-macrophages expressing activation markers. Absence of villitis was associated
with an increase in the number of Hofbauer cells, which expressed PD-L1. Scattered neutrophil extracellular
traps (NETs) were identified by immunofluorescence.
Interpretation: We provide first-time evidence for maternal-fetal transmission of SARS-CoV-2, likely propa-
gated by circulating virus-infected fetal mononuclear cells. Placenta infection was associated with recruit-
ment of maternal inflammatory cells in the intervillous space, without villitis. PD-L1 expression in
syncytiotrophoblast and Hofbaeur cells, together with limited production of NETs, may have prevented
immune cell-driven placental damage, ensuring sufficient maternal-fetus nutrient exchanges.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
(http://creativecommons.org/licenses/by-nc-nd/4.0/)V. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)1. Introduction
The COVID-19 pandemic has caused high levels of morbidity
and mortality throughout the world, becoming a serious public
health problem. The infection is caused by severe acute
respiratory
Research in the context
Evidence before this study
Several recent reports have addressed the question whether
SARS-Cov-2 infection can be propagated from the mother to
the fetus during pregnancy. Based on current data, evidence for
vertical transmission of the SARS-CoV-2 infection is missing.
Whereas detection of SARS-CoV-2 RNA in placental tissue has
been recently documented, mechanisms limiting the spreading
of virus infection to the newborn remain unknown. Distribu-
tion, composition and activation status of immune /inflamma-
tory cells in placenta of COVID-19 pregnant women, remains
undetermined.
Added value of this study
This study analyzed by immunohistochemistry the expres-
sion of SARS-CoV-2 Spike (S) protein in 101 placentas (includ-
ing 15 from COVID-19 proved positive women) collected in
Brescia, Italy during the SARS-Cov-2 pandemics. A single case
showed robust expression of the S protein, as well as the N
(nucleocapsid) protein in the syncytiotrophoblast. In addition,
in situ hybridization for SARS-CoV-2 RNA demonstrated intense
signal in the syncytiotrophoblast and in intervillous inflamma-
tory cells, and ultrastructural analysis identified viral particles
morphologically consistent with coronavirus localized in the
cytoplasm of syncytiotrophoblast cells, in fetal capillaries endo-
thelium, fibroblasts, as well as in fetal intravascular mononu-
clear cells. Histopathological analysis of the immune/
inflammatory cell infiltrate suggests that intervillous presence
of activated monocyte-macrophages and neutrophils may rep-
resent an histological marker of SARS-CoV-2 infection of the
placenta. This unique histopathological setting of the placenta
coincided with early onset of COVID-19 disease in the newborn,
consistent with vertical transmission of the infection.
Implications of all the available evidence
Together with previous reports, our study on 101 placentas
from mothers collected in the COVID-19 pandemic stage docu-
ments that mother-to-fetus transmission of SARS-CoV-2 infec-
tion is a rare yet documented event. The findings provided in
this study reveal the passage of SARS-CoV-2 across the mater-
nal-fetal interface to infect fetal-derived cells of the placenta.
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gle-stranded virus, member of the Betacoronavirus genus that
includes also SARS-CoV and MERS-CoV responsible of previous epi-
demic diseases.
The effects and consequences of COVID-19 on pregnant women
and their infants remain poorly understood [1]. The adverse effects
on women infected with SARS-CoV-2 during the first trimester are
uncommon and may lead to early pregnancy loss [1,2]. Several recent
reports describing individual cases or cohorts of COVID-19 women
infected during the third trimester of pregnancy, have indicated that
maternal complications are generally similar to those occurring in
non-pregnant women [14], but an increased prevalence of preterm
deliveries was noticed [2].
The increasing number of reports describing neonates born from
women with COVID-19, with signs of early-onset infection [1,3,5] is
compatible with a scenario of trans-placental transmission of SARS-
CoV-2. However, vertical transmission of the virus remains contro-
versial, with clinical and laboratory evidences considering it a rare
event [24,610]. Notably, a cause-effect relationship between virus
infection and unfavorable outcome of neonates has not been formally
proven, as other factors causing post-partum complications cannot
be excluded [1,8]. Therefore, uncertainty remains whether an earlyneonatal SARS-CoV-2 infection occurs in utero, during the delivery,
or soon after birth [11].
Testing for SARS-CoV-2 presence by reverse transcriptase PCR has
repeatedly failed to identify the presence of the viral genome in
maternal and neonatal specimens including placenta, umbilical cord
blood, amniotic fluid or amniotic swab, maternal blood, vaginal
secretions and breastmilk [2,7,8,12,13].
The detection of SARS-CoV-2 RNA in placental or membrane sam-
ples, supporting the possibility of vertical transmission of the infec-
tion has been reported for the first time by Penfield et al.. [14]
Authors detected viral RNA in 3 out of 11 samples from COVID-19
positive women, all presenting with moderate to severe disease at
time of delivery. However, none of the infants tested positive for
SARS-CoV-2 from postnatal day-1 through 5, and none showed
symptoms of COVID-19 infection.
Recently, two studies have provided further evidence for the pres-
ence of SARS-CoV-2 in the placenta, localizing it to syncytiotropho-
blast cells at the maternal-fetal interface. In the study by Hosier et al.
[15] a second-trimester pregnant woman with symptomatic COVID-
19 had severe preeclampsia and placental abruption. SARS-CoV-2
virus was detected in the placenta by molecular and immunohisto-
chemical assays and by electron microscopy. Molecular analysis on
tissue samples of the fetus obtained by autopsy resulted negative for
the virus. In another study, two neonates born from symptomatic
COVID-19 women resulted positive by nasopharyngeal swab testing
immediately after birth and at day-7 post-partum, but none of them
developed infection-related symptoms. The placenta from both cases
was positive for SARS-CoV-2 by in situ hybridization and RT-PCR
analysis [16].
Here, we report a case of a COVID-19 positive full-term pregnant
woman with pneumonia and severe thrombocytopenia requiring
childbirth induction. The neonate was positive for the presence of the
virus and twenty-four hours after birth developed pneumonia and
severe respiratory distress. SARS-CoV-2 viral products and/or par-
ticles were detected in villous syncytiotrophoblast, endothelial cells,
fibroblasts and maternal macrophages contributing to the inflamma-
tory infiltrate, as well as in Hofbauer cells. Remarkably, for the first
time, particles morphologically consistent with coronavirus were
localized in fetal circulating mononuclear cells.
In accordance with previous reports, the placental tissue con-
tained an inflammatory infiltrate occupying the intervillous spaces.
Comprehensive immunophenotyping analysis revealed that the infil-
trate was composed of monocyte-macrophages displaying activation
markers and both morphologically/phenotypically mature and
immature neutrophils. Screening for SARS-CoV-2 proteins failed to
identify positive cases among the remaining 100 placentas obtained
from deliveries occurred during the pandemic period, which included
14 cases from COVID-19 positive mothers whose newborns tested
negative. In summary, our observations provide proof for the occur-
rence at low frequency of intrauterine vertical transmission of SARS-
CoV-2 infection with clinical consequences for the newborn.
2. Materials and methods
2.1. Study participants
Brescia Spedali Civili Hospital is one among the Italian hospitals
with the highest incidence of patients treated for COVID-19 infection.
Starting from March 9, 2020, the Department of Obstetrics and Gine-
cology has been recognized as Regional Center for the handling of
SARS-CoV-2 positive pregnant women. Between March 13 and May
4, SARS-CoV-2 RNA RT-PCR testing on nasopharyngeal swabs was
selectively performed on women with positive clinical, laboratory or
instrumental criteria. In particular, patients were tested for the pres-
ence of SARS-CoV-2 within 14 days of admission, upon presentation
of at least one of the followings: fever > 375 °C, cough, sore throat,
Table 1
Main morphological changes observed in the placentas from the 15 COVID-19
positive woman.
CASE PLACENTAL WEIGHT (g)and
[percentile] (*)
HISTOPATOLOGY [19,40]
1 448 [2550] Histiocytic-neutrophilic intervil-
lositis




2 472 [2550] Borderline massive perivillous
fibrin deposition
3 440 [2550] Maternal vessels thrombosis of
capsularis decidua
Focal acute chorioamnionitis
4 240 [510] Infarct
Intervillous hematoma
5 435 [2550] Normal
6 429 [7590] Maternal decidual vasculopathy
7 542 [5575] Chorionic plate infarct
Borderline massive perivillous
fibrin deposition
8 400 [1025] Small infarcts
Acute deciduitis
Focal distal villous immaturity
9 444 [2550] Transmural massive perivillous
fibrin deposition
Infarct and acute deciduitis
Accelerated villous maturation









12 790 [ >90] Accelerated villous maturation
Subchorial hematoma
13 582 [7590] Accelerated villous maturation
Intervillous hematomas
Chorangiosis
14 440 [25] Marginal infarct




* Percentiles and standard deviations for placental weights by gestational age.
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anamnesis of symptomatic relatives, close non protected contacts
with COVID-19 confirmed cases, or when any of the following labora-
tory and instrumental tests at admission was present: lymphopenia,
increase of transaminases unrelated to preeclampsia or gravidic hep-
atopathy, increased CRP, LDH, and pulmonary X-Ray or echography
showing SARS-CoV-2 correlated interstitial pneumonia [17]. Starting
May 5, all hospitalized patients were tested for SARS-CoV-2 RNA.
From February 7 to May 15, 2020 101 placentas were collected,
including 15 from women who tested positive for the SARS-CoV-2
RNA by RT-PCR, 34 tested negative for the presence of the virus, and
52 were not screened as they did not meet the above reported testing
criteria (32), or delivered before COVID-19 pandemic declaration
(20). We also included in the study 9 placentas examined in 2017
and 2018, showing respectively normal features (2 cases), cytomega-
lovirus infection (3) villitis (3) and villitis plus intervillositis (1).
The study was performed in accordance with Brescia Spedali Civili
Hospital Institutional Ethical Board protocols and approved by the
institutional review board (NP #4151 COVID-BIO and NP #4133
INTERCOVID). Written informed consent to pathology examination of
the placenta and to its use for research-oriented testing was obtained
from all participants, in accordance with the Declaration of Helsinki
for Human Research.
2.2. Clinical records
The data of mothers and neonates of the COVID-19 positive and
negative cases are reported in the supplementary Appendix. Details
on the clinical history of the index case (Case #1), including the evo-
lution of pregnancy, the childbirth stages and support interventions,
the clinical parameters of the newborn, and treatments applied to
the mother and child are reported in Marzollo et al. [18].
Briefly, a 29 years-old woman was hospitalized at 37 weeks + 5 of
her first pregnancy, for fever (380 C°) and idiopathic thrombocyto-
penia, diagnosed at the beginning of the pregnancy. She tested posi-
tive for SARS-CoV-2 RNA and X-ray imaging showed parenchymal
lung thickening (COVID-19 pneumonia 3/18 score) [17]. Due to fever
and thrombocytopenia worsening, a vaginal delivery was induced,
with supportive ventilation due to the onset of 95% O2 saturation in
room air. The male newborn weighted 2840 Kg and presented an
APGAR score of 9/10. Twenty-four hours post-partum he developed
fever, breathing difficulty, vomiting, abdominal distension, hypoto-
nia, and cutaneous mild erythema. Chest X-ray revealed interstitial
pneumonia and he was transferred to intensive care unit, where
mechanical ventilation was applied. After birth test for SARS-CoV-2
RNA on nasopharyngeal swab resulted inconclusive (amplification of
less than three genes), while it was positive 36 and 72 h after birth
and at the age of 17-days.
After delivery, the mother rapidly recovered, fever decreased and
the puerperal course proceeded normally. The child was discharged
on day-18 after birth in good general conditions. Two months after
the delivery both mother and baby were healthy and asymptomatic.
2.3. Pathological examination
All placentas were fixed in 10% buffered formalin, weighed
trimmed of cord and membranes and sampled according to the
Amsterdam’s guidelines [19]. The histological examination was per-
formed by a pathologist experienced on fetal-placental pathology,
who was not aware of the clinical diagnosis and COVID-19 status.
The histological findings on placentas from the 15 COVID-19 positive
women are reported in Table 1, whereas those on the 86 non COVID-
19 positive women are listed in Table 4 s of the Appendix.
All cases were stained by immunohistochemistry for the SARS-
CoV-2 S-protein using formalin fixed paraffin embedded sections.
The 15 placentas from COVID-19+ women were stained also for theSARS-CoV-2 N-protein. For the single placenta tested positive for
SARS-CoV-2 proteins, the inflammatory infiltrate as well as other cell
types of the placenta were studied using a comprehensive set of anti-
bodies tested in single or double immunostains. Immunophenotyp-
ing was extended to the inflammatory infiltrate of placentas showing
villitis associated or not with an intervilllous inflammatory compo-
nent (Case 15, 29, 32, 53, 61, 63, 99 and 101). The list of antibodies
used and their specificities are reported in the Appendix. Placenta
from Case #1 tested positive for SARS-CoV-2, after detecting the pres-
ence of S-protein-specific transcripts by RNA-in situ hybridization.
Sections were subsequently immunostained to detect the expression
of the CD14 antigen. SARS-CoV-2 RNA RT-PCR analysis, immunofluo-
rescence microscopy to identify Neutrophil Extracellular Traps
(NETs), negative stain electron microscopy and transmission electron
microscopy were performed as reported in the Appendix.2.4. Statistical analysis
Hofbauer cell number in placenta from Case #1 was compared to
that of a reference group of controls. For analysis of changes, two-
tailed paired t-test was applied.
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3.1. Histological, immunohistochemical and in situ SARS-CoV-2 RNA
analyses of placenta
The monoamniotic-monocorial placenta of Case #1 weighted 448
gr (2550 percentiles for age). No significant abnormalities were
detected on cord insertion, cord vessels, fetal surface and mem-
branes, while the dark brown colored chorionic parenchyma con-
tained multiple small pale areas (Appendix). On microscopical
examination, the chorionic plate on both fetal and maternal sites
showed multiple foci (corresponding to around 40% of the total sur-
face) with intervillous inflammatory infiltrate, composed of numer-
ous monocytoid cells and macrophages and mature neutrophils. In
areas showing inflammation, villi displayed variable changes com-
patible with fetal vascular malperfusion with avascular villi and
stroma-vascular karyorrhexis. Fibrin perivillous deposition was
prominent in many areas. In the remaining parenchyma normal villi
and focal chorangiosis were observed. No intra-villous inflammatory
infiltrate (villitis) was evident (Appendix)
Immunostains for SARS-CoV-2 proteins showed positivity in the
cytoplasm of the syncytiotrophoblast for both S-protein and N-pro-
tein (Fig. 1A and B). N-protein was also expressed by rare intervillous
macrophages and Hofbauer cells. Notably, while anti-nucleocapsid
staining was homogenously strong throughout the placental paren-
chyma, the immunoreactivity to S-protein was variable and particu-
larly strong in areas with abundant intervillous inflammation
(Fig. 1C). SARS-CoV-2 proteins were not detected in villous
capillaries.
Immunophenotyping showed a heterogeneous composition of
inflammatory cells, which mostly consisted of monocyte-macro-
phages and neutrophils (Fig. 1D). The former strongly expressed
CD11c, CD14, CD68, and CD163. Most of them were also positive for
CD16, and about 10% co-expressed myeloperoxidase (Appendix),
while CD66b was negative. Stain for PD-L1 showed weak to moderate
positivity in a proportion of these cells (Fig. 1E). The neutrophils sub-
sets included both mature cells expressing CD10, CD11c, CD15, CD16,
myeloperoxidase, CD66b and Arginase markers, and immature
cells with monocytoid morphology lacking CD10 expression [20]
(Appendix).
Notably, the comparison between Case #1 and the remaining pla-
centas, including the fourteen from COVID-19-positive women, did
not show significant morphological differences, except for the promi-
nent intervillous inflammation and its mixed monocyte-macrophage
and neutrophil composition. Furthermore, all other cases showing
variable degree of inflammation in the intervillous area were associ-
ated with villitis and the presence of CD68+CD14+CD163+ monocyte-
macrophages and scattered CD3+ T-lymphocytes, while very rare
CD66b+ neutrophils were detected (Appendix).
In light of the high number of neutrophils in Case #1, we tested by
immunofluorescence microscopy the presence of Neutrophil Extra-
cellular Traps (NETs)(Appendix). We observed a high density of
nuclear debris marked by DAPI and citrullinated Histone H3 (H3cit),
but only rare myeloperoxidase-positive cells in which a H3cit/DAPI
thread was detected, thus indicating a limited representation of
NETosis (Appendix).
The absence of intravillous inflammation was confirmed by
immunostains for markers identifying different T-cell subsets, B cells,
NK cells and plasmacytoid dendritic cells (Appendix). Notably Hofba-
uer macrophages were significantly increased in number (Fig. 1D and
Appendix) and, in areas of inflammation, expressed PD-L1, which is
otherwise absent on these cells (Fig. 1E). The Hofbauer cell hyperpla-
sia was confirmed by comparing the number of CD163+ cells in termi-
nal villi in the SARS-CoV-2+ placenta (average 57§ 45 SD cells per
villous) to those of sixteen control samples, including cases
with inflammation unrelated to SARS-CoV-2 (n = 10 and n = 6 fromCOVID-19 positive and negative patients, respectively; 39§ 25/vil-
lous SD)(t-test for independent means: p < 0001). The difference
was stronger when we evaluated only villi displaying inflammation
in the SARS-CoV-2 positive placenta (6.7 cells/villous).
In areas of inflammation we found prominent platelet deposition
revealed by antibodies recognizing the megakaryocyte and platelet
associated antigens CD61, LAT/Linker for Activation of T-cells and
CXCR4 (Appendix). In placentas from six control cases, platelet aggre-
gates were rare and mostly located on the contour of stem villi. Nota-
bly, staining with the three antibodies also identified villous intra-
capillary megakaryocytes (Appendix), whose number in the SARS-
CoV-2 positive case was three times higher than in seven controls
(47 versus 14 per mm2 of parenchyma). In rare capillaries, loose
aggregates of platelets but no fibrin thrombi were found.
In keeping with evidence of syncytiotrophoblast damage in villi
associated with the intervillous inflammatory infiltrate, we found
thinning, or even discontinuity of this cell layer by cytokeratin stain
(Appendix). Interestingly, in the same areas, the syncytiotrophoblast
was positive for PD-L1 staining, with a less defined expression
pattern compared to non-inflamed areas (Fig. 1E).
3.2. RNA in situ hybridization
SARS-CoV-2 RNA in situ hybridization (ISH) using the S antisense
probe showed intense signal positivity in the syncytiotrophoblast,
with a distribution similar to that detected for the S-protein by
immunohistochemistry (Fig. 1F). SARS-CoV-2 S-specific transcripts
tested positive also in scattered cells in the intervillous areas, most of
which were represented by CD14-expressing monocytes-macro-
phages (Fig. 1F).
3.3. Electron Microscopy (EM)
Electron microcopy of formalin-fixed placental tissue revealed
fine morphologic preservation. On negative stain EM (nsEM), we
observed particles morphologically compatible with coronavirus.
They consisted of round particles with an external “corona” made
of peplomers, and their size ranged between 85 and 90 nm to
110120 nm (including peplomers). Isolated coronavirus but also
couples or small clusters of particles were identified (Fig. 2A and
Appendix).
On ultrathin sections coronavirus resembling particles were
easily identified by their mostly spherical shape, with intermediate
electron density cores, often surrounded by an envelope covered
with faint surface projections (peplomeric spikes). The diameter of
these particles was similar to the one measured by nsEM, and con-
sistent with size and appearance of both SARS-CoV [21] and SARS-
CoV-2 (Fig. 2B) [22]. Viral particles localized predominantly in the
cytoplasm of syncytiotrophoblast cells as single particle or small
groups, either dispersed or within small vesicles. Moreover,
electron-dense granular material corresponding to nucleocapsid
inclusions were found (Fig. 2C1C2) [21]. In addition to the syncy-
tiotrophoblast localization, virus particles were identified in
the endothelium of fetal capillaries close to the villus surface
(Fig. 2 C3C4 and Fig. 2DD1) and in fibroblasts. Importantly, par-
ticles morphologically consistent with coronavirus were detected
in the cytoplasm of intra-capillary cells, likely corresponding to
monocytes (Fig. 3AB), indicating a possible role of these cells in
the spread of the infection to the fetus.
4. Discussion
In this study we provide evidence in support of transmission of
the SARS-CoV-2 infection from a COVID-19 full term pregnant
woman to her newborn, who resulted positive for SARS-CoV-2 and
developed pneumonia soon after birth. Viral proteins and RNA were
Fig. 1. Immunohistochemical and RNA-in situ stains.
(A, B) Immunostainings for SARS-CoV-2 spike (A) and nucleocapsid (B) proteins. Syncytiotrophoblast is positive for both proteins. Note the more extensive and stronger positiv-
ity for nucleocapsid expression, which also localizes to intervillous inflammatory cells (inset, arrowheads) and an Hofbauer cell (inset, arrow).
(C) Double stain for spike protein (brown) and CD14 (blue) indicates higher density of inflammatory infiltrate at sites where the viral protein is more intensely expressed.
(D) Double staining for CD14 (brown) and CD66b (blue) expression, respectively identifying monocyte-macrophages and neutrophils in the inflammatory infiltrate occupying
the intervillous spaces. Note the CD14-positive Hofbauer cells in the villi.
(E) PD-L1 staining shows strong expression in the syncytiotrophoblast in areas displaying inflammation (left side). The inset shows an area infiltrated with inflammatory cells,
which express PD-L1 (arrow), similarly to intravillous Hofbauer cells.
(F) SARS-CoV-2 RNA in situ hybridization using the S antisense probe (brown stain) combined with anti-CD14 immunostain (red stain). Strong expression of viral RNA is
observed in the syncytiotrophoblast, and in scattered CD14+ intervillous mononuclear cells, identified as monocyte-macrophage (inset, arrowheads). (Bar corresponds to 100 mm
for figs. A-B-B inset-C-F, 50mm for fig. D and F inset, 200mm for fig. E and 150 mm for E inset).
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inflammatory cells. Moreover, particles consistent with coronavirus
were identified by electron microscopy in villous syncytiotropho-
blast, endothelial cells, fibroblasts, and, most notably, fetal intravas-
cular monocytes. Infection by SARS of infiltrating monocytes and
macrophages has been documented in human tissues [23,24]. The
hitherto unreported presence of SARS-CoV-2 in circulating cells is in
keeping with the detection of SARS-CoV-2 RNA in blood samples
from COVID-19 patients [25]. These results raise the hypothesis that
fetal blood cells infected with SARS-CoV-2 represent a vehicle of the
infection.Fetal placental site infection by SARS-CoV-2 has been recently
reported in other three cases, but no SARS-CoV-2 RNA was
detected in fetal tissues [15] and neither of the two newborns
developed SARS-CoV-2 related disease [16]. As previously shown,
we detected viral S-protein and RNA in villous syncytiotropho-
blast. We found stronger expression of S-protein in areas with
dense monocyte-macrophage inflammation, compatible with a
local activation of these immune cells in response to the binding
to anti-Spike maternal IGG-virus immune complexes, as shown in
lung tissues [26]. A broader and stronger positivity for SARS-CoV-
2 N-protein was detected in the same cells and in maternal and
Fig. 2. Electron microscopy study of placenta.
(A, B) Negative stain electron micrograph of particles obtained from a homogenate of formalin-fixed placenta (A, bar 100 nm) and ultrathin sections of free particle in the cyto-
plasm of a syncytiotrophoblast cell (B, bar 100 nm). In both cases morphological features consistent with coronavirus are observed.
(C) Ultrathin sections of a villous. The right and the left squares include a portion of the syncytiotrophoblast and of a capillary vessel; the respective details are illustrated in fig.
C1-C2 and C3-C4. In C2 the arrow points to an aggregate of SARS-Cov-2 nucleocapsid inclusions, the arrowhead to a particle consistent with mature coronavirus. In C4 the arrow
points to a particle with the typical morphological features of coronavirus within the endothelium. (C1, bar 2mm; C2, bar 1mm; C3, bar 2mm; C4, bar 250 nm).
(D, D1) The endothelium of a fetal capillary (D, bar 5 mm) close to the villus surface shows particles morphologically consistent with SARV-CoV-2 in the cytoplasm (D1, high
magnification of the area shown in C, bar 500 nm).
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evidence that the N-protein can be produced twice as much as
the S protein in Coronavirus-infected cells [2730], even in the
absence of complete virus particle assembly [21,22], as witnessed
in the syncytiotrophoblast cells.Whereas our findings cannot rule out ongoing clearance of viral
particles or infected cells by macrophages [27], the strong positivity
for SARS-CoV-2 N-protein in these antigen-presenting cells is com-
patible with potent immunogenicity conferred by this protein to dif-
ferent SARS viruses [28]. Indeed, a restricted IGG-specific anti-N
Fig. 3. Electron microscopy of SARS-CoV-2 viral particle within an intra-capillary monocyte.
(A, B) In the cytoplasm of an intra-capillary monocyte (A, bar 5mm) a particle morphologically consistent with coronavirus is present (B, high magnification of the area shown in
A, bar 100 nm).
F. Facchetti et al. / EBioMedicine 59 (2020) 102951 7antibody response [31] was recently shown to exert an important
role in host immunity in COVID-19 patients [27,32].
Despite chorionic villi associated with intervillous inflammation
and significant cell damage contained virus particles in different cell
types, there was no evidence of active recruitment of intravillous
inflammatory cells. The only sign of local inflammatory activation
was linked to Hofbauer cell hyperplasia. Similar findings were
reported in studies of placenta of fetuses with congenital Zika virus
infection [33], where infected Hofbauer cells were proposed to elimi-
nate viruses by secreting type-I interferon and by upregulating anti-
viral genes [34]. Despite the lack of definite explanations for the
missed recruitment of inflammatory cell to the villi, it may depend
on de novo expression of the check-point inhibitor PD-L1 by Hofba-
uer cells and the syncytiotrophoblast.
The two previous studies on SARS-CoV-2 infected placentas
defined the intervillous inflammatory infiltrate as “chronic histiocytic
intervillositis” [35] on the basis of the single CD68 marker. In the
present study, using a comprehensive set of markers, we describe
instead a composite pool of inflammatory cell types, consisting of
monocyte-macrophages and mature and immature neutrophils.
Notably, a proportion of the monocyte-macrophages cells expressed
PD-L1 in combination with myeloperoxidase, indicating an activated
state [36]. The presence of a substantial pool of monocytic-macro-
phages and neutrophils is uncommon in normal and pathological pla-
cental conditions, with the exception of so called "immunological"
preeclampsia [37], where intervillous neutrophils are associated with
high triggering of Neutrophil Extracellular Traps (NETs) and severe
tissue damage [38]. Future studies will establish whether the pres-
ence of a mixed monocytic-macrophage and neutrophil infiltrate rep-
resents an histological marker of SARS-CoV-2 placenta infection.
Aberrant NETs formation has been recently observed in lungs
autopsy specimens from COVID-19 patients with neutrophil-rich
inflammation, suggesting a role for NETs in the development of com-
plications of SARS-CoV-2 infection [39]. Immunofluorescence micros-
copy analyses of the placenta of COVID-19 Case #1 revealed a high
density of nuclear debris marked by DAPI and citrullinated Histone
H3 (H3cit). However, only rare myeloperoxidase-positive cells
with a H3cit/DAPI thread were detected, thus pointing to a minor
contribution of NETosis to the inflammatory response ongoing in
SARS-CoV-2-infected placental tissue.
In conclusion, the detection of SARS-CoV-2 in the placenta of
COVID-19 Case #1, distributed in multiple fetal cell types, includingcirculating cells, combined with the failure to reveal SARS-CoV-2
S-protein expression in remaining 100 placentas from deliveries dat-
ing to the pandemic period, including 14 from women tested positive
for COVID-19, establishes the infrequent occurrence of mother-to-
fetus SARS-Cov-2 transmission with adverse effects on the newborn.
Whether the rare permissiveness of trans-placental SARS-CoV-2
transmission seen in COVID-19 Case #1 depended on host genetic
factor(s), the infection with a unique SARS-CoV-2 genetic variant,
and/or the production of a high load of maternal antibody-virus
immune complexes contributing to antibody-dependent enhance-
ment of the infection awaits future investigations.5. Contributors
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